NEW YORK, March 16 (GenomeWeb News) - High-Throughput Genomics has been awarded a two-year, $500,000 grant from the National Cancer Institute to identify and validate sets of genes for toxicity studies and develop a new array product, the company said today.
HTG said it plans to make "two-pronged" use of the funds, awarded by NCI's Division of Cancer Treatment & Diagnosis.
The company first plans to identify and validate a set of genes that can be used to predict the toxicity of compounds before testing in animals or humans. HTG said it will also use the funds to develop and validate a new medium-density array -- measuring 75 to 300 genes per well - to measure DNA, RNA, or protein molecules.